Latest Ai Platforms News

Nuix Limited reported a slight revenue increase to $221.5 million for FY25 but swung to a net loss of $9.2 million, weighed down by rising legal fees and restructuring costs. The company’s AI-driven Nuix Neo platform showed strong contract growth, while cash EBITDA improved significantly.

Credit Clear Limited has reported a remarkable turnaround in FY25, posting record revenue growth and a return to profitability driven by its innovative AI-powered debt resolution platform.

Janison Education Group reported a 9% revenue increase in FY25, driven by new contracts and the launch of its AI-powered assessment platform, Jai. The company also expanded its customer pipeline by 80%, positioning itself for sustained growth in digital education.

Janison Education Group reported a 9% revenue increase to $47 million in FY25, driven by new contracts and strong ICAS performance, while launching its AI-powered assessment platform Jai. The company also refreshed its leadership and expanded its customer pipeline to $28.6 million.

dorsaVi Ltd has raised A$5 million through a strategic placement to accelerate development of its next-generation RRAM-enabled sensors and robotics platforms, signaling a bold expansion into edge AI and neuromorphic computing.

Opyl Limited has formalized its partnership with UK-based Innovatrix Capital, positioning its AI platform TrialKey at the forefront of clinical trial failure insurance. This deal not only validates Opyl’s technology but also opens doors to global biotech markets and valuable data streams.

Prophecy International and Complexica announce a strategic merger to form MergeCo, an ASX-listed AI pure play with enhanced scale, product synergies, and growth potential.

Codeifai Limited advances its fintech and cybersecurity ambitions by acquiring a cutting-edge quantum-secure AI platform and a leading QR code competitor, backed by a $2.35 million capital raise.

Decidr AI Industries reported an 82% revenue jump in its AI platform during Q4 FY25, launched AI Mentors with The Growth Faculty, and divested its 13Seeds business to sharpen focus on AI innovation.

MONEYME has exceeded its FY25 operating cash profit expectations by 20%, driven by robust loan book expansion and improved credit quality, while gearing up for a major credit card launch.

Algorae Pharmaceuticals has advanced its AI-driven drug discovery platform into preclinical validation through a strategic collaboration with the Peter MacCallum Cancer Centre, while progressing its therapeutic pipeline and commercial leadership.

Pureprofile has reported record FY25 results, with revenue climbing 19% and EBITDA up 18%, driven by strong international growth and innovative AI platform launches.